tiprankstipranks
Trending News
More News >
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
Advertisement

Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?

Compare
362 Followers

Candel Therapeutics (CADL) Ownership Overview

20.35%17.19%11.65%5.95%44.86%
20.35% Insiders
11.65% Other Institutional Investors
5.95% ETFs
44.86% Public Companies and
Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 34.79% of the company’s stock is owned by Institutional Investors, 20.35% is owned by Insiders, and 44.86% is owned by Public Companies and Individual Investors.
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 28.83% of the company’s stock is owned by Institutional Investors, 20.35% is owned by Insiders, and 5.95% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 17, 2025
xxxxxxxxxxxxx
$75290
Jan 17, 2025
xxxxxxxxxxxxx
$103405
Jan 17, 2025
xxxxxxxxxxxxx
$68669
Jan 17, 2025
xxxxxxxxxxxxx
$97715

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$87249
Jun 30, 2025
xxxxxxxxxxxxx
$1796866

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution10.40%33,768,922
5,197,821Insider9.75%31,654,730
4,431,832Insider8.31%26,989,857
1,669,374Institution3.13%10,166,488
1,362,454Institution2.56%8,297,345
1,356,174Institution2.54%8,259,100
1,069,921Institution2.01%6,515,819
546,863Insider1.03%3,330,396
355,112Institution0.67%2,162,632
323,453Institution0.61%1,969,829

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution10.40%33,768,922
1,356,174Institution2.54%8,259,100
1,069,921Institution2.01%6,515,819
323,453Institution0.61%1,969,829
315,222Institution0.59%1,919,702
167,728Institution0.31%1,021,464
105,633Institution0.20%643,305
83,880Institution0.16%510,829
76,136Institution0.14%463,668
17,664Institution0.03%107,574

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,083,691Institution2.03%6,984,389
933,963Institution1.75%5,687,835
389,281Institution0.73%2,508,916
311,898Institution0.58%1,899,459
187,056Institution0.35%1,205,576
90,138Institution0.17%544,434
31,738Institution0.06%204,551
30,797Institution0.06%186,014
23,985Institution0.04%146,069
19,778Institution0.04%119,459

FAQ

Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 11.65% of the company's stock is held by institutional investors, 20.35% is held by insiders, and 44.86% is held by retail investors.
    What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 11.65% of Candel Therapeutics (CADL) stock is held by institutional investors.
      What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 44.86% of Candel Therapeutics (CADL) stock is held by retail investors.
        Who owns the most shares of Candel Therapeutics (CADL)?
        Fidelity Select Portfolios owns the most shares of Candel Therapeutics (CADL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis